Immunogenicity and safety of IXIARO® (IC51) in a Phase II...

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

A. Kaltenböck, K. Dubischar-Kastner, E. Schuller, Mahima Datla, C.S. Klade, T.S.A. Kishore
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Year:
2010
Language:
english
DOI:
10.1016/j.vaccine.2009.10.024
File:
PDF, 144 KB
english, 2010
Conversion to is in progress
Conversion to is failed